These challenges are being addressed with recent developments leading to high-throughput assays of customized NGS-based panels. These panels can examine clinically relevant genes, allowing rapid ...

In the deal, GenomOncology will integrate Pillar's RUO NGS panels into its clinical decision support platform to enable personalized cancer treatment insights.

announces the North American launch of its new next-generation sequencing (NGS) SureSeq Myeloid MRD Panel, which provides a flexible NGS workflow for the detection of ultra-low frequency measurable ...

GenomOncology, a precision medicine software company, and Pillar Biosciences, a leader in Decision Medicine™, today announced ...

Download this application note to learn how a comprehensive target enrichment panel enables scientists to detect highly ...

next-generation sequencing (NGS) can be used to identify viruses without existing sequence knowledge. Existing target enrichment panels substantially increase the analytical sensitivity of NGS for ...

NGS library preparation kits with carefully curated NGS panels, and comprehensive software for variant calling data analysis and interpretation. The combined technologies will provide an end-to ...